Predictive
Oncology (NASDAQ: POAI) on Monday announced that it repaid or extended
the secured promissory notes that were due September 28, 2019. POAI repaid the
remaining principal and interest balance of $478,590 on one note on September
27th. The company also secured a new investment of $700,000 from a private
investor in exchange for a new 8% secured promissory note due on March 27, 2020
with an original principal amount of $847,500. POAI issued 88,574 shares of
common stock and a 682,368 share warrant to the new investor. The company also
amended the other outstanding note to extend the maturity date from September
28, 2019 to December 31, 2019. The outstanding principal amount of the note was
increased by $120,000 to $1,789,104, and the company issued 150,000 shares of
common stock to the investor per the amended terms.
To view the full press release, visit http://ibn.fm/FbRay
About Predictive Oncology Inc.
Predictive Oncology operates in two business areas: first,
applying artificial intelligence to personalized medicine and drug discovery to
provide personalized medicine solutions for patients and clinicians as well as
clients in the pharmaceutical, diagnostic, and biotech industries, and second,
production of the FDA-approved STREAMWAY® System for automated, direct-to-drain
medical fluid disposal. For more information, visit the company’s website
at www.Predictive-Oncology.com.
NOTE TO INVESTORS: The latest news and updates relating
to POAI are available in the company’s newsroom at http://ibn.fm/POAI
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
